More About This Company
Development Update
Novo Nordisk announced the European Commission (EC) has granted marketing authorisation for Rybelsus®, (oral semaglutide),...
Study: Pharmacokinetics of Oral Cyanocobalamin Formulated with SNAC
Originally published by Elsevier Journals on 24 May 2011, this white paper outlines an open-label,...
Emisphere Development Update
Novo Nordisk has announced the Federal Food and Drug Administration (FDA) approved Rybelsus, a semaglutide...